IL6 and COVID-19: Due to their central roles in driving harmful inflammation and downstream pathological cascades, TNF-α, IL-6, and IL-1 have been extensively investigated as therapeutic targets in sepsis and other cytokine storm-related conditions, such as severe COVID-19.